Medicine composition for curing hepatic encephalopathy and hepatitis B

Abstract

The invention provides a medicine composition for curing hepatic encephalopathy and hepatitis B, belonging to the field of Chinese materia medica prescriptions. The composition comprises the following components in parts by weight: 5-50 parts of rheum officinale, 10-60 parts of roxburgh rose root, 5-30 parts of black soya bean, 20-90 parts of serissa serissoide, 20-100 parts of Salviacavaleriei, 30-150 parts of siphonostegia chinensis, 5-40 parts of pubescent holly root and 10-60 parts of liquorice. In the medicine composition, pathogenesis and symptomatic treatment are taken as the principal thing; the medicine composition has the efficacies of clearing away heat and toxic material, removing dampness through diuresis, cooling blood, eliminating stasis, stop bleeding, eliminating heat and relaxing the bowels, thus achieving the effects of resisting viruses, cooling the blood, reducing bloodammonia, eliminating excreta reserved in bowel, reducing absorption of toxin in intestinal tracts, protecting a liver and a brain, and preventing and curing the encephalopathy and the hepatitis B.

Description

technical field [0001] The invention relates to a pure traditional Chinese medicine composition, in particular to a pure traditional Chinese medicine composition for treating hepatic encephalopathy and hepatitis B, and belongs to the field of traditional Chinese medicine prescriptions. Background technique [0002] Hepatitis B (full name: hepatitis B virus) is a worldwide disease caused by the hepatitis B virus (HBV). The incidence rate in developing countries is relatively high. According to statistics, there are more than 280 million asymptomatic hepatitis B virus carriers (HBsAg carriers) in the world, and my country accounts for about 130 million. Most of them are asymptomatic, and 1 / 3 of them have clinical manifestations of liver damage. At present, there are 30 million hepatitis B patients in our country. Prolonged treatment of hepatitis B can also cause pathological changes in the liver of patients, leading to liver cell degeneration, necrosis, inflammatory cell inf...

AI Technical Summary

Problems solved by technology

[0004] At present, there are many drugs for the treatment of hepatitis B in the clinic. There are both traditional Chinese medicine compound preparations and chemical drugs. The chemical drugs are mainly interferon and nucleotide compounds. Both of them have disadvantages such as long taking time and low cure rate.

Drugs for the treatment of hepatic encephalopathy are mainly used in combination with a variety of chemical drugs, and there has been no report on the use of a single traditional Chinese medicine prescription for the treatment of hepatic encephalopathy

Images